A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
Hello all, ol In the attached revised draft, I jections, I will submit these to D) (e)] PM AID DEA DART NIAID) [E] i \IH/NIAID) [E] ii || NIH/NIAID) [E] NIAID) [E] VIH/NIAID) [E] iy >; || (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] has asked us to ze We will be sure Please let me know if you have any questions. () 1AM [AID DEA DART ID DIR-OCGR < VIH/NIAID) [--] i I Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara
-
Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara
-
2024-07-15 10:35
Sara Selgrade
Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara
-
Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara
-
Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara ol D) () PM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii a NIH/NIAID) [E] VIH/NIAID) [E] iy >; || (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] has asked us to ze We will be sure Please let me know if you have any questions. ) 1AM [AID DEA DART ID DIR-OCGR < NIH/NIAID) [E] )() ay P| >; Billet,
-
Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara